Summary
Direxion Daily S&P Biotech Bull 3X Shares is an ETF - a fund traded on an exchange like a stock - run by Direxion. Positions inside: 173. The ten largest make up 254% of the fund.
- Yearly costs
- 0.96%
- Fund size
- $574.8M
- Positions
- 173
- Dividend yield
- 0.47%
- Running since
- 2015
What speaks for it
- Easy to buy and sell: about $95.6M changes hands a day.
- It has been running since 2015.
What to watch
- The ten largest positions make up 254% of the fund, so its result rests on a few names.
- 99% of the fund is in one sector (Healthcare).
- 96% of the fund is in one country (United States).
- High costs: 0.96% a year.
- In the last five years its price once dropped by 99% from its high.
A fund has no Bulios Score and no Fair Price of its own - both are computed from the results of a single company. This page shows what is inside the fund and what it costs instead.
Price
Performance
- 1 month
- -19%
- 3 months
- -15%
- This year
- +34%
- 1 year
- +73%
- 3 years
- +276%
- 5 years
- -79%
- 10 years
- -70%
- Avg. market cap
- $41.7B
- P/E
- -
- Forward P/E
- -
- P/S
- 9.6x
- P/B
- 6.0x
- P/FCF
- -
- EV/EBITDA
- -
- Dividend yield
- 0.18%
- ROIC
- -14.2%
- ROE
- -20.4%
- Gross margin
- 33.9%
- Operating margin
- -809.0%
- Net margin
- -315.4%
- Payout ratio
- -
- Net debt/EBITDA
- -
- Beta
- 3.09
Weighted average of the 50 largest companies, which make up 50% of the fund. Banks and insurers are left out of the gross margin, the ROIC and the EBITDA figures.
What is inside?
Concentrated- 1 SPSIBI SWAP ASSET LEG (SPSIBIUBL) 52%
- 2 SPSIBI SWAP ASSET LEG (SPSIBIMLL) 48%
- 3 SPSIBI SWAP ASSET LEG (SPSIBICTL) 43%
- 4 SPSIBI SWAP ASSET LEG (SPSIBIBCL) 38%
- 5 SPSIBI SWAP ASSET LEG (SPSIBIJPL) 32%
- 6 GOLDMAN FINL SQ TRSRY INST 506 16%
- 7 SPSIBI SWAP ASSET LEG (SPSIBIBPL) 10%
- 8 DREYFUS GOVT CASH MAN INS 9.6%
- 9 SPSIBI SWAP ASSET LEG (SPSIBIGSL) 2.8%
- 10 MRModerna MRNA 1.9%
Positions in the fund: 173. The ten largest make up 254% of it.
Composition as of Oct 18, 2026.
Where is it spread?
One sector dominatesBy sector
- Healthcare 99%
- Financials 0.7%
By country
- United States 96%
- Switzerland 1.4%
- Ireland 1.4%
- United Kingdom 1.3%
- Other countries 0.5%
By company size
- Mega cap 3.4%
- Large cap 28%
- Mid cap 49%
- Small cap 19%
- Micro cap 0.5%
By the company's market value: Mega cap from $200B, Large cap from $10B, Mid cap from $2B, Small cap from $300M, Micro cap below $300M. Counted from the companies that make up 73% of the fund.
Largest sector: Healthcare (99%). Largest country: United States (96%). Largest size group: Mid cap (49%).
What does it cost me?
Expensive- Yearly costs
- 0.96%
- A year from $10,000
- $96.00
- Over 20 years
- $4,453
From every $10,000 invested the fund takes $96.00 a year. You do not pay it separately - it is taken out of the fund's value. Over 20 years at 5% yearly growth that adds up to about $4,453.
How has it done?
Losing value- A year on average, 10 years
- -11%
- Deepest drop
- -99%
- Yearly volatility
- 86%
Average yearly decline over the last ten years: 11%. Deepest drop in these years: 99% below the earlier high.
Does it pay dividends?
Yes, it pays out- Yield
- 0.47%
- Payments a year
- 4
- Last payment
- $0.91
Over the last 12 months it paid $1.01 per share, which is 0.47% of today's price. The last payment was $0.91 on Dec 23, 2025.
Is it easy to buy and sell?
Very easy- Traded a day
- $95.6M
- Shares a day
- 448K
On an average day about $95.6M of the fund changes hands.
How expensive are the companies inside?
Rather expensive- Average Bulios Score
- 47 out of 100
Weight by Bulios Fair Price
- Undervalued 22%
- Fairly valued 11%
- Overvalued 67%
By Fair Price, 67% of the rated weight comes out as overvalued.
Counted from its largest companies (50), which make up 50% of the fund. Each company counts by its weight. We use the metrics, the Bulios Score and the Fair Price of the companies themselves.
Similar funds
Funds that hold much of the same. The overlap says how much of their weight they share with this fund.
| Fund | Domicile | Size | 1-year change | Dividends | ||
|---|---|---|---|---|---|---|
XB XBI SPDR S&P Biotech ETF | United States | 0.35% | $7.55B | +34% | Pays out | 73% |
CU CURE.AX Global X - S&P Biotech ETF | Australia | 0.45% | $27.4M | +25% | Reinvests | 73% |
TD TDNA T. Rowe Price Biotech ETF | United States | 0.55% | $9.09M | - | - | 46% |
IB IBB iShares Biotechnology ETF | United States | 0.44% | $10.5B | +30% | Pays out | 38% |
IB IBBQ Invesco Nasdaq Biotechnology ETF | United States | 0.19% | $79.9M | +30% | Pays out | 38% |
2B 2B70.DE iShares Nasdaq US Biotechnology UCITS ETF | Ireland | 0.35% | $906.2M | +37% | Reinvests | 38% |
